RedHill's Antibiotic Approach For Crohn's Shows Promise, Caveats Remain
Top-line data for a Phase III trial of RedHill's antibiotic combination for use in Crohn's disease show the study has hit its primary endpoint, but there is still some way to go before filings can be made for the novel approach.
